Assessing the Clinical Treatment Dynamics of Antiplatelet Therapy Following Acute Coronary Syndrome and Percutaneous Coronary Intervention in the US

IMPORTANCE: A platelet ADP P2Y12 receptor (P2Y12) inhibitor plus aspirin is standard therapy for patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). Compared with clopidogrel, prasugrel and ticagrelor are associated with superior antiatherothrombotic effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yehua, Cavallari, Larisa H., Brown, Joshua D., Thomas, Cameron D., Winterstein, Almut G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111179/
https://www.ncbi.nlm.nih.gov/pubmed/37067798
http://dx.doi.org/10.1001/jamanetworkopen.2023.8585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111179/
https://www.ncbi.nlm.nih.gov/pubmed/37067798
http://dx.doi.org/10.1001/jamanetworkopen.2023.8585

Ejemplares similares